Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Antibiotic Delivery for Community Acquired Pneumonia
NCT07843017Phase 3Not yet recruiting
- Sponsor
- Copenhagen Respiratory Research
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 3 trial of Levofloxacin inhalation solution in community acquired pneumonia (CAP), sponsored by Copenhagen Respiratory Research. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Levofloxacin inhalation solution
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07843017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843017.